Antithrombotic activity of protein S infused without activated protein C in a baboon thrombosis model

Mary J. Heeb, Ulla Marzec, Andras Gruber, Stephen R. Hanson

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Protein S (ProS) is an essential plasma protein that enhances the anticoagulant activity of activated protein C (APC). In vitro, purified native human Zn 2+-containing ProS also exerts direct anticoagulant activity by inhibiting prothrombinase and extrinsic FXase activities independently of APC. We investigated antithrombotic effects of ProS infused without APC in a baboon shunt model of thrombogenesis that employs a device consisting of arterial and venous shear flow segments. In in vitro experiments, the Zn 2+-containing human ProS used for the studies displayed >10-fold higher prothrombinase inhibitory activity and anticoagulant activity in tissue factor-stimulated plasma, and four-fold higher inhibition of the intrinsic pathway than the Zn 2+-deficient ProS used. In the thrombosis model, ProS (33 μg/minute for 1 hour) or saline was infused locally; platelet and fibrin deposition in the shunt were measured over 2 hours. During experiments performed at 50 ml/minute blood flow, Zn 2+-containing ProS inhibited platelet deposition 73-96% in arterial-type flow segments and 90-99% in venous-type flow segments; Zn 2+-deficient ProS inhibited platelet deposition 52% in arterialtype flow segments and 65-73% in venous-type flow segments. At 100 ml/min blood flow rate, Zn 2+-containing ProS inhibited platelet deposition by 39% and 73% in the respective segments; Zn 2+-deficient ProS inhibited platelet deposition by 5% and 0% in the respective segments. Zn 2+-containing ProS suppressed fibrin deposition by 67-90%. Systemic APC-independent ProS activity was significantly increased and thrombin-antithrombin complex levels were significantly decreased after infusion of ProS. Thus, infused human Zn 2+-containing ProS is antithrombotic in primates, and may have therapeutic potential even in protein C-deficient human patients.

Original languageEnglish (US)
Pages (from-to)690-698
Number of pages9
JournalThrombosis and Haemostasis
Volume107
Issue number4
DOIs
StatePublished - Apr 2012

Fingerprint

Papio
Protein S
Protein C
Thrombosis
Blood Platelets
Thromboplastin
Anticoagulants
cancer procoagulant
Fibrin
Zn-proline
Population Groups
Primates
Blood Proteins
Equipment and Supplies

Keywords

  • Anticoagulants
  • Platelets
  • Protein S
  • Thrombosis model

ASJC Scopus subject areas

  • Hematology

Cite this

Antithrombotic activity of protein S infused without activated protein C in a baboon thrombosis model. / Heeb, Mary J.; Marzec, Ulla; Gruber, Andras; Hanson, Stephen R.

In: Thrombosis and Haemostasis, Vol. 107, No. 4, 04.2012, p. 690-698.

Research output: Contribution to journalArticle

Heeb, Mary J. ; Marzec, Ulla ; Gruber, Andras ; Hanson, Stephen R. / Antithrombotic activity of protein S infused without activated protein C in a baboon thrombosis model. In: Thrombosis and Haemostasis. 2012 ; Vol. 107, No. 4. pp. 690-698.
@article{d476bed43ae849c0a9a1c5a90435a79c,
title = "Antithrombotic activity of protein S infused without activated protein C in a baboon thrombosis model",
abstract = "Protein S (ProS) is an essential plasma protein that enhances the anticoagulant activity of activated protein C (APC). In vitro, purified native human Zn 2+-containing ProS also exerts direct anticoagulant activity by inhibiting prothrombinase and extrinsic FXase activities independently of APC. We investigated antithrombotic effects of ProS infused without APC in a baboon shunt model of thrombogenesis that employs a device consisting of arterial and venous shear flow segments. In in vitro experiments, the Zn 2+-containing human ProS used for the studies displayed >10-fold higher prothrombinase inhibitory activity and anticoagulant activity in tissue factor-stimulated plasma, and four-fold higher inhibition of the intrinsic pathway than the Zn 2+-deficient ProS used. In the thrombosis model, ProS (33 μg/minute for 1 hour) or saline was infused locally; platelet and fibrin deposition in the shunt were measured over 2 hours. During experiments performed at 50 ml/minute blood flow, Zn 2+-containing ProS inhibited platelet deposition 73-96{\%} in arterial-type flow segments and 90-99{\%} in venous-type flow segments; Zn 2+-deficient ProS inhibited platelet deposition 52{\%} in arterialtype flow segments and 65-73{\%} in venous-type flow segments. At 100 ml/min blood flow rate, Zn 2+-containing ProS inhibited platelet deposition by 39{\%} and 73{\%} in the respective segments; Zn 2+-deficient ProS inhibited platelet deposition by 5{\%} and 0{\%} in the respective segments. Zn 2+-containing ProS suppressed fibrin deposition by 67-90{\%}. Systemic APC-independent ProS activity was significantly increased and thrombin-antithrombin complex levels were significantly decreased after infusion of ProS. Thus, infused human Zn 2+-containing ProS is antithrombotic in primates, and may have therapeutic potential even in protein C-deficient human patients.",
keywords = "Anticoagulants, Platelets, Protein S, Thrombosis model",
author = "Heeb, {Mary J.} and Ulla Marzec and Andras Gruber and Hanson, {Stephen R.}",
year = "2012",
month = "4",
doi = "10.1160/th11-10-0699",
language = "English (US)",
volume = "107",
pages = "690--698",
journal = "Thrombosis and Haemostasis",
issn = "0340-6245",
publisher = "Schattauer GmbH",
number = "4",

}

TY - JOUR

T1 - Antithrombotic activity of protein S infused without activated protein C in a baboon thrombosis model

AU - Heeb, Mary J.

AU - Marzec, Ulla

AU - Gruber, Andras

AU - Hanson, Stephen R.

PY - 2012/4

Y1 - 2012/4

N2 - Protein S (ProS) is an essential plasma protein that enhances the anticoagulant activity of activated protein C (APC). In vitro, purified native human Zn 2+-containing ProS also exerts direct anticoagulant activity by inhibiting prothrombinase and extrinsic FXase activities independently of APC. We investigated antithrombotic effects of ProS infused without APC in a baboon shunt model of thrombogenesis that employs a device consisting of arterial and venous shear flow segments. In in vitro experiments, the Zn 2+-containing human ProS used for the studies displayed >10-fold higher prothrombinase inhibitory activity and anticoagulant activity in tissue factor-stimulated plasma, and four-fold higher inhibition of the intrinsic pathway than the Zn 2+-deficient ProS used. In the thrombosis model, ProS (33 μg/minute for 1 hour) or saline was infused locally; platelet and fibrin deposition in the shunt were measured over 2 hours. During experiments performed at 50 ml/minute blood flow, Zn 2+-containing ProS inhibited platelet deposition 73-96% in arterial-type flow segments and 90-99% in venous-type flow segments; Zn 2+-deficient ProS inhibited platelet deposition 52% in arterialtype flow segments and 65-73% in venous-type flow segments. At 100 ml/min blood flow rate, Zn 2+-containing ProS inhibited platelet deposition by 39% and 73% in the respective segments; Zn 2+-deficient ProS inhibited platelet deposition by 5% and 0% in the respective segments. Zn 2+-containing ProS suppressed fibrin deposition by 67-90%. Systemic APC-independent ProS activity was significantly increased and thrombin-antithrombin complex levels were significantly decreased after infusion of ProS. Thus, infused human Zn 2+-containing ProS is antithrombotic in primates, and may have therapeutic potential even in protein C-deficient human patients.

AB - Protein S (ProS) is an essential plasma protein that enhances the anticoagulant activity of activated protein C (APC). In vitro, purified native human Zn 2+-containing ProS also exerts direct anticoagulant activity by inhibiting prothrombinase and extrinsic FXase activities independently of APC. We investigated antithrombotic effects of ProS infused without APC in a baboon shunt model of thrombogenesis that employs a device consisting of arterial and venous shear flow segments. In in vitro experiments, the Zn 2+-containing human ProS used for the studies displayed >10-fold higher prothrombinase inhibitory activity and anticoagulant activity in tissue factor-stimulated plasma, and four-fold higher inhibition of the intrinsic pathway than the Zn 2+-deficient ProS used. In the thrombosis model, ProS (33 μg/minute for 1 hour) or saline was infused locally; platelet and fibrin deposition in the shunt were measured over 2 hours. During experiments performed at 50 ml/minute blood flow, Zn 2+-containing ProS inhibited platelet deposition 73-96% in arterial-type flow segments and 90-99% in venous-type flow segments; Zn 2+-deficient ProS inhibited platelet deposition 52% in arterialtype flow segments and 65-73% in venous-type flow segments. At 100 ml/min blood flow rate, Zn 2+-containing ProS inhibited platelet deposition by 39% and 73% in the respective segments; Zn 2+-deficient ProS inhibited platelet deposition by 5% and 0% in the respective segments. Zn 2+-containing ProS suppressed fibrin deposition by 67-90%. Systemic APC-independent ProS activity was significantly increased and thrombin-antithrombin complex levels were significantly decreased after infusion of ProS. Thus, infused human Zn 2+-containing ProS is antithrombotic in primates, and may have therapeutic potential even in protein C-deficient human patients.

KW - Anticoagulants

KW - Platelets

KW - Protein S

KW - Thrombosis model

UR - http://www.scopus.com/inward/record.url?scp=84859316481&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859316481&partnerID=8YFLogxK

U2 - 10.1160/th11-10-0699

DO - 10.1160/th11-10-0699

M3 - Article

C2 - 22370911

AN - SCOPUS:84859316481

VL - 107

SP - 690

EP - 698

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 4

ER -